Mark N. Wegman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 17,000 shares at $52.56 ($895K) on 2018-08-23, disclosed to the SEC on 2018-08-23.
Open-market sale of $895k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.71 | 3,802 | $200K | 22.4% |
| 2 | $52.71 | 3,802 | $200K | 22.4% |
| 3 | $52.56 | 4,698 | $247K | 27.6% |
| 4 | $52.56 | 4,698 | $247K | 27.6% |
| Total | $52.63 avg | 17,000 | $895K | 100% |
| Filing → |
| BSTC | SELL | 2019-05-22 | $768K | — | Filing → |
| BSTC | SELL | 2018-09-11 | $374K | — | Filing → |